Live feed
·
INSIDERFilingvia Quantisnow
Precipio Inc. logo

Precipio (PRPO) director Andrews received 1,000 Stock Option (Right to Buy)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Ronald Asbury Andrews (director at Precipio Inc., PRPO) reported that they received 1,000 Stock Option (Right to Buy) on Jan 14, 2025.

Reporting person
Andrews Ronald Asbury

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 14, 2025Grant or award (A)Stock Option (Right to Buy)On 1,000 Common Stock1, 2+1,000--1,000 direct

Holdings before and after

  • Stock Option (Right to Buy): 0 to 1,000 direct

Footnotes from the filing

  1. 1. The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.
  2. 2. Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Andrews report in this PRPO Form 4?

Ronald Asbury Andrews (director at Precipio Inc., PRPO) reported that they received 1,000 Stock Option (Right to Buy) on Jan 14, 2025.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for PRPO

Earlier insider filings at PRPO

Quantisnow market dataNASDAQ
Precipio Inc. logo
PRPO
Precipio Inc.
Market cap
30-day
Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Get push alerts for PRPO

Follow PRPO and get a push notification the moment its next story breaks.

Full PRPO profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRPO (Precipio Inc.) and more on Quantisnow.